SEC Comment Letter for COMPUGEN LTD (CGEN) (CIK 0001119774) (CGEN) — Oct 5, 2016
COMPUGEN LTD (CGEN) (CIK 0001119774)
Date: Oct. 5, 2016 · CIK: 0001119774 · Accession: 0000000000-16-095978
AI Filing Summary & Sentiment
File numbers found in text: 000-30902
Show Raw Text
Mail Stop 4546 October 5 , 2016 Via E -mail Anat Cohen -Dayag, Ph.D. President and Chief Executive Officer Compugen Ltd. 26 Harokmim Street Holon 5885849, Israel Re: Compugen Ltd. Annual Report on Form 20-F Filed March 7 , 2016 File No. 000-30902 Dear Dr. Cohen -Dayag: We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filin g and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all per sons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Suzanne Hayes Suzanne Hayes Assistant Director Office of Healthcare and Insurance cc: Brian P. Keane , Esq. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.